Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/11 → 4/30/13 |
Funding
- NovaRX Corporation
An International, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of Luacnix Maintenance Therapy for Stages III/IV NSCLC Subjects Who Have Responded to or Have Stable Disease Following One
- Mullett, Timothy (PI)